4d Molecular Therapeutics had a rough day and is now down -5.29%. Investors weren't too impressed with the future outlook for the asset which caused some selling on weak demand.
4d Molecular Therapeutics doesn't seem to be at a very clear reversal point in either direction. 4d Molecular Therapeutics has been drifting up over the last few months, we'll see if it has the energy to keep moving in the right direction. It might slide down to the $10.01 level and find some buyers to give it support.
